Should you buy KROS stock?
Last updated:
Based on market data through , StockInvest.us rates Keros Therapeutics Inc. (KROS) as a Buy Candidate with a technical score of 4.01 on its -10 to +10 scale. This is an upgrade from Hold in the previous daily evaluation.
- Buy signal since
- Price since signal Flat 0.00%
- 3-month trend forecast Down 5.63%
- High gross margin of 94.7%
- Low bankruptcy risk (Altman Z-Score: 5.99)
- Highly efficient cash conversion (101% FCF/OCF ratio)
Keros Therapeutics Inc. stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session
(Market data through Aug 07, 2026)
The Keros Therapeutics Inc. stock price gained 4.69% on the last trading day (Friday, 7th Aug 2026), rising from $10.65 to $11.15. During the last trading day the stock fluctuated 6.43% from a day low at $10.58 to a day high of $11.26. The price has risen in 6 of the last 10 days and is up by 10.83% over the past 2 weeks. Volume fell on the last day by -68 thousand shares and in total, 319 thousand shares were bought and sold for approximately $3.55 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.63% during the next 3 months and, with a 90% probability hold a price between $8.76 and $11.13 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
KROS Signals & Forecast
Mostly positive signals in the chart today. The Keros Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $10.35 and $10.72. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, July 29, 2026, and so far it has risen 11.84%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Keros Therapeutics Inc. stock
Keros Therapeutics Inc. finds support from accumulated volume at $10.99 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.680 between high and low, or 6.43%. For the last week, the stock has had daily average volatility of 5.78%.
Our recommended stop-loss: $10.78 (-3.32%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 7 days ago.)
Trading Expectations (KROS) For The Upcoming Trading Day Of Monday 10th
For the upcoming trading day on Monday, 10th we expect Keros Therapeutics Inc. to open at $11.00, and during the day (based on 14 day Average True Range), to move between $10.89 and $11.41, which gives a possible trading interval of +/-$0.513 (+/-4.71%) up or down from last closing price. If Keros Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 4.71% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $11.23 (0.72%) than the support at $10.99 (1.43%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Keros Therapeutics Inc. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
4.008
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on August 10, 2026 - $11.00 ( 1.38%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
KROS Performance
Trading levels for KROS
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 11.68 | 4.72% |
| R2 | 11.42 | 2.39% |
| R1 | 11.26 | 0.95% |
| Price | 11.15 | |
| S1 | 10.74 | -3.71% |
| S2 | 10.58 | -5.15% |
| S3 | 10.32 | -7.48% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 11.65 | 4.48% |
| R2 | 11.26 | 0.99% |
| R1 | 11.23 | 0.717% |
| Price | 11.15 | |
| S1 | 10.99 | -1.43% |
| S2 | 10.98 | -1.52% |
| S3 | 10.65 | -4.48% |
FAQ
Click here for our free guide on how to buy Keros Therapeutics Inc. Stock.
Buy KROS
A buy signal from a double bottom formation was found on Wednesday, June 10, 2026 and based on theory for this formation the price should go up by 9.83% to $12.25 within 15 trading days (Thursday, July 02, 2026) since signal was issued.